You have been here long enough to know he has taken a month or so off from buying. He will be buying even at thirty, so it is not price, OR PENDING news.
I repeat above plus now 6 up days, 4 new highs in a row, all shorts in red, NEED more volume, way more volume.
If they can tap it down another couple percent they will buy more. They were one of the top holders until this quarter, in time they will be again if they can manipulate things properly.
I was not so much thinking about a squeeze than that the Astra news if positive would attract more buyers, funds, etc., trying to buy shares with little/no float. If not enough shares but extra buyers no squeeze is needed. With over 100% ownership arry is in that situation. The average pt is 10, but the two higher targets are 13 and 15. Enough buyers on Astra news could push this above consensus to the two higher targets. Shorts need not cover one share.
Not sure I have ever seen a stock 100% owned by funds before. So it is actually well over 100% owned if you figure retail. Sometimes these funds do short against their shares, so many market games. With the appearance of 20m negative float, if the Astra news is positive in the next 90 days, a 3.00 move might be too little. Will be interesting to see the volume and price move that day. If funds hold tight, retail owns a bulk of that 20m.
The nice part was three consecutive new highs, and three consecutive new closing highs on descent volume. I say descent volume because opk has had far higher volume in the past, and for far longer periods of time. To end the week with every short in the red for the third day in a row is nice, umm, I get a nice feeling knowing this. I know 5 consecutive up days is nice, we had 7 in Jan., so it would not be unprecedented or a first to run a day or two more. We have had 6 consecutive new highs this past Feb, so one never knows. If we did get three more that could get opk to 18, current new high 17.24 so not far fetched. My thought is too, part of this move was only a mini squeeze, many are sitting back praying for a big pull back to cover. Volume needs get well over the recent 7m, say 12m followed by 16m, on up days to really get a squeeze going. If that happened, not saying it will, opk could spike 2-4 over two days. This 5 day move was 2.79, so a 2-4 dollar move on double the recent 7m volume is not out in left field.
I was in the process of updating my ignore list to include any poster with bust or splat in the heading, when your post showed up. Umm, makes my reading list and pages about as empty as the posts I ignored.
New member since 2 minutes ago? Oh sorry 27 minutes ago. Is this the same Morton who said Avon buyout? I see the news NOWHERE. HOPE it is not true.
Congrats on the win by the way, tough getting it right when you put in the first price, but then you have an open number line to choose from. Enjoy the Corona, have a second for me.
Funny, I never even saw the contest, say robo everyone. I would not have won most likely, but it is a nice diversion.
The recent selling was options, nothing unusual. A while back one board member who was also a fund manger sold out. The net of those options was insiders who owned little, do own more now than before. Also note, the newer options have strike prices of 7.30 and 8.20. Most of the sales were a cost basis of ZERO and part of a pay in stock bonus for the NVS deal. 100% taxable event. These guys are not paid millions upon millions like some. In fact none makes a million, but close.
Miami, I enjoy your posts. I report those clowns to Yahoo every time they show no respect for their mother. Insulting the women on this board, is no different. Makes me sick to think how they must treat her, or heaven forbid their wives.
If I was their dad, they wouldn't be able to walk for a month, I would likely go to jail too boot. Then again, if I was their dad, maybe the right thing to do would be to hand them the switch to beat me, for my failing them as a parent.
It is possible they were raised right, but were accidentally dropped on their head, damaged, and now post here spewing hate.
Ignore button is so over worked.
Miami fan, and LONG. SORRY for the RANT
Opk was up .17, after a revenue beat, some said it would not hold. Tuesday day 2, opk up .51, total 2 day gain .68, noway it holds, no way 3 up days. Wednesday, opko up .86, after someone said, day's 1 and two gains would not hold. Someone who claims longs are idiots for predicting what opk will do hypocritically kept PREDICTING a fall. Day 4, Opko can not keep going up off this excellent earnings report we were all told this. Day 4 opko runs up 1.01, noway. NOT POSSIBLE.
The predictor said day one-day 4 would not hold. 4 day's up a total 2.55. No pull back yet, ouch predictor, guy who knows the future, where do they find guys like this, always saying what opko will do, predicting the future based on NOTHING. Day 5, ummm, we will see, hehe, but the spin might be can't hold 17, like the same lame noise about not holding 15.
Y/Y revenue growth I PREDICT will be north of 50%, based on umm, facts.
If you look at many of the opko 4k news releases you notice Memorial Sloan is mentioned in many, I believe they were one of the original 13, NCCN members, now 29 members. Only 20 on the PC committee, Sloan is one of 20 as I stated.
ntended to aid clinicians in deciding if a prostate cancer is high risk and requires biopsy, the 4Kscore test analyzes four kallikrein protein markers – total prostate specific antigen, free PSA, intact PSA, and hK2 – combined with patient age and digital rectal exam status to determine the likelihood of aggressive disease.
The biomarkers were identified by researchers at Sweden's University of Malmo, Finland's University of Turku, and New York's Memorial Sloan Kettering Cancer Center and have been tested in more than 10,000 patients to date, Opko said.
NCCN guidelines are set up by members from about twenty hospitals, groups etc. I believe one of Memorial Sloan Kettering people helped design 4k. MSK is on the prostate c committee, BUT I do not know if they will have to abstain from voting due to conflicts. If they do not step down, it is virtually a lock, but they still only have 1 vote out of 20, if that's a lock, lol. That said, they WILL push for it, they have a bit of time involved in the test and have been on the PC for a long time, and part of nccn guidelines as one of the earlier members.
If I had to be an odds maker in Vegas on getting in I'd say about 95% in favor because of the MSK connection to the test.
The hope is it becomes standard of care and becomes part of the nccn guidelines. If that does happen then the Majority of drs. will not preform a biopsy before doing 4k, and the number of biopsies will drop to about 250k. The number of 4k tests done will be around 1 million. As far as revenue per test that has not been negotiated with ANYONE yet, but it will not be 1,185. If they get 500-600 I will figure they did well. My 500-600 number is just a guess, but if it is in that range, a little higher or lower, the math is easy. 1m x ?
With the insurance coverage the usage will ramp up slowly over time, getting in the guidelines is the key to instant national use, and media coverage.
That move in Jan had a few .50 moves, over a couple month period, umm, no 15% moves in 3 days, or even 10 days. 10% moves then were coming every 3-4 weeks. Oct. 2013 it did have a similar move but most came in one day, and marked a 1.5 year high mark. Whatever, this move is different because of the % move over a 3 day span.